U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C87H95Cl3N16O28S2
Molecular Weight 1983.265
Optical Activity UNSPECIFIED
Defined Stereocenters 20 / 20
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of CEFILAVANCIN

SMILES

CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]5C[C@](C)(N)[C@H](O)[C@H](C)O5)C6=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]7C8=CC=C(O)C(=C8)C9=C(O)C=C(O)C=C9[C@H](NC(=O)[C@@H](NC7=O)[C@H](O)C%10=CC=C(O6)C(Cl)=C%10)C(=O)NCCCO\N=C(/C(=O)N[C@H]%11[C@H]%12SCC(C[N+]%13=CC=CC=C%13)=C(N%12C%11=O)C([O-])=O)C%14=C(Cl)SC(N)=N%14)C(Cl)=C2

InChI

InChIKey=OGUAFUAJSPORAH-KHCCTVBNSA-N
InChI=1S/C87H95Cl3N16O28S2/c1-33(2)20-45(94-5)74(117)100-62-66(112)36-11-14-49(43(88)22-36)130-51-24-38-25-52(70(51)134-85-71(69(115)68(114)53(31-107)132-85)133-55-29-87(4,93)72(116)34(3)129-55)131-50-15-12-37(23-44(50)89)67(113)63-81(124)99-59(42-26-40(108)27-48(110)56(42)41-21-35(10-13-47(41)109)57(77(120)101-63)98-78(121)58(38)97-75(118)46(28-54(91)111)96-80(62)123)76(119)95-16-9-19-128-104-61(60-73(90)136-86(92)103-60)79(122)102-64-82(125)106-65(84(126)127)39(32-135-83(64)106)30-105-17-7-6-8-18-105/h6-8,10-15,17-18,21-27,33-34,45-46,53,55,57-59,62-64,66-69,71-72,83,85,94,107,112-116H,9,16,19-20,28-32,93H2,1-5H3,(H15-,91,92,95,96,97,98,99,100,101,102,103,104,108,109,110,111,117,118,119,120,121,122,123,124,126,127)/t34-,45+,46-,53+,55-,57+,58+,59-,62+,63-,64+,66+,67+,68+,69-,71+,72+,83+,85-,87-/m0/s1

HIDE SMILES / InChI

Molecular Formula C87H95Cl3N16O28S2
Molecular Weight 1983.265
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 20 / 20
E/Z Centers 2
Optical Activity UNSPECIFIED

Cefilavancin is a covalently-linked glycopeptide-cephalosporin (beta-lactam) heterodimer antibiotic that exhibits substantially greater activity than its component parts against Gram-positive bacteria.

Approval Year

Substance Class Chemical
Created
by admin
on Mon Mar 31 22:22:47 GMT 2025
Edited
by admin
on Mon Mar 31 22:22:47 GMT 2025
Record UNII
F76229E21M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CEFILAVANCIN
INN   WHO-DD  
INN  
Official Name English
cefilavancin [INN]
Preferred Name English
Cefilavancin [WHO-DD]
Common Name English
VANCOMYCIN, 26-(((3-(((Z)-(1-(2-AMINO-5-CHLORO-4-THIAZOLYL)-2-(((6R,7R)-2-CARBOXY-8-OXO-3-(PYRIDINIOMETHYL)-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-7-YL)AMINO)-2-OXOETHYLIDENE)AMINO)OXY)PROPYL)AMINO)CARBONYL)-26-DECARBOXY-
Systematic Name English
TD-1792
Code English
Code System Code Type Description
FDA UNII
F76229E21M
Created by admin on Mon Mar 31 22:22:47 GMT 2025 , Edited by admin on Mon Mar 31 22:22:47 GMT 2025
PRIMARY
CAS
722454-12-8
Created by admin on Mon Mar 31 22:22:47 GMT 2025 , Edited by admin on Mon Mar 31 22:22:47 GMT 2025
PRIMARY
DRUG BANK
DB05735
Created by admin on Mon Mar 31 22:22:47 GMT 2025 , Edited by admin on Mon Mar 31 22:22:47 GMT 2025
PRIMARY
INN
9881
Created by admin on Mon Mar 31 22:22:47 GMT 2025 , Edited by admin on Mon Mar 31 22:22:47 GMT 2025
PRIMARY
SMS_ID
300000034092
Created by admin on Mon Mar 31 22:22:47 GMT 2025 , Edited by admin on Mon Mar 31 22:22:47 GMT 2025
PRIMARY
PUBCHEM
76960417
Created by admin on Mon Mar 31 22:22:47 GMT 2025 , Edited by admin on Mon Mar 31 22:22:47 GMT 2025
PRIMARY
NCI_THESAURUS
C169833
Created by admin on Mon Mar 31 22:22:47 GMT 2025 , Edited by admin on Mon Mar 31 22:22:47 GMT 2025
PRIMARY